Ono Starts Phase I Trial For Hepatocellular Carcinoma Vaccine
This article was originally published in PharmAsia News
Executive Summary
Ono Pharmaceuticals submitted a clinical trial notification for a Phase I trial with ONO-7268MX2, a liver cancer vaccine introduced by the bio-venture company OncoTherapy Science Inc.